Author:
Horvath Philipp,Beckert Stefan,Struller Florian,Königsrainer Alfred,Reymond Marc André
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference31 articles.
1. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1995) Surgery for exocrine pancreatic cancer—who are the 5- and 10-year survivors? Oncology 52(5):353–359
2. Beger HG, Rau B, Gansauge F, Leder G, Schwarz M, Poch B (2008) Pancreatic cancer—low survival rates. Dtsch Arztebl Int 105(14):255–262
3. Heeckt P, Safi F, Binder T, Büchler M (1992) Free intraperitoneal tumors cells in pancreatic cancer—significance for clinical course and therapy. Chirurg 63(7):563–567
4. Sudo K, Ishihara T, Hirata N et al (2014) Randomized controlled study of gemcitabine plsu S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemother Pharmacol 73:389–396
5. Tabarnero J, Chiorean EG, Infante JR et al (2015) Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. Oncologist 20:143–150
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献